RedC Biotech

Universal Red Blood Cells for Life Saving Transfusions and Advanced Therapies

Health Tech & Life Sciences
Active
Pre-Seed Bnei Zion Founded 2015
Total raised
$3.0M
Last: Pre-Seed 2023-06
Stage
Pre-Seed
Founded
2015
Headcount
5
HQ
Bnei Zion
Sector
Health Tech & Life Sciences

About

RedC Biotech is a pre-clinical, development stage company aiming at saving lives worldwide. RedC is developing a new, process, to create universal red blood cells from stem cells using a patented cultivation technology. It is a highly scalable process for production that can meet the global demand for safe red blood cell transfusions for anyone, anywhere. The universal red blood cells provided by RedC Biotech will be a blood type that is suitable for almost every patient and will have the same potency as the currently used red blood cell transfusion

RedC Biotech collaborates with leading industry, academia and government organizations.

Funding history · 3 rounds · $3.0M total

2023-06
Pre-Seed $1.1M
2020-05
Equity crowdfunding $1.1M
2018-04
Pre-Seed $300K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is RedC Biotech's primary focus?
RedC Biotech is a pre-clinical, development stage company focused on creating universal red blood cells from stem cells using a patented cultivation technology for life-saving transfusions and advanced therapies.
When was RedC Biotech founded?
RedC Biotech was founded in April 2015.
What is RedC Biotech's total funding to date?
RedC Biotech has raised a total of $3,000,000 USD.
When did RedC Biotech receive its most recent funding round?
RedC Biotech received a Pre-Seed funding round in June 2023, amounting to $1,100,000 USD.
Which investor led RedC Biotech's equity crowdfunding round?
PipelBiz was the lead investor in RedC Biotech's equity crowdfunding round in May 2020.
Has RedC Biotech received any grants?
Yes, RedC Biotech received a grant of $500,000 USD from the IIA in March 2022.
How many employees does RedC Biotech currently have?
RedC Biotech currently has 5 employees.
What is the current product stage of RedC Biotech?
RedC Biotech's product is currently in the R&D stage.
Has RedC Biotech been recognized in any competitions?
Yes, Ari Gargir from RedC Biotech won the Ziv Aviram Fund competition in Dubai in March 2022, and RedC Biotech was also noted as a winner in the 'Startup of Israel' competition in April 2020.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
BiologicalsCells
Target customers
Defense, Safety & SecurityHealthcare & Life SciencesHealthcareProvidersLaboratoriesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

biomaterialshealthcare-providershospitalsbiotechnologyclinicsstem-cells